Cambridge Nutrition

A Cambridge University Press publication examines how nutritional support affects clinical disease progression and malnutrition in patients with inflammatory bowel disease. The work addresses a longstanding question in managing Crohn's disease and ulcerative colitis, where malnutrition is a common complication. Clinicians and researchers are weighing the findings for their implications on dietary therapy as part of standard patient care.

Cambridge Nutrition has issued a TR-1 Notification of Major Holdings, a standard regulatory disclosure under UK rules that must be filed when an investor's stake in a company crosses a disclosure threshold. The filing confirms a change in share ownership at the company, though the specific shareholder and stake size were not given in the headline notice.